Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia Article

Wang, Dongfang, Cheng, Sunny Lihua, Fei, Qiang et al. (2019). Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia . PSYCHIATRY RESEARCH, 272 18-29. 10.1016/j.psychres.2018.12.008

International Collaboration

cited authors

  • Wang, Dongfang; Cheng, Sunny Lihua; Fei, Qiang; Gu, Haiwei; Raftery, Daniel; Cao, Bing; Sun, Xiaoyu; Yan, Jingjing; Zhang, Chuanbo; Wang, Jingyu

sustainable development goals

authors

publication date

  • February 1, 2019

webpage

published in

keywords

  • Biomarker
  • DISEASE
  • Global metabolic profiling
  • IN-VIVO
  • LIPIDOMICS
  • LYSOPHOSPHATIDYLCHOLINE
  • Life Sciences & Biomedicine
  • Liquid chromatography-mass spectrometry
  • MEMBRANE PHOSPHOLIPIDS
  • Metabolomics
  • PLASMA
  • PREFRONTAL CORTEX
  • Phospholipid
  • Psychiatry
  • Schizophrenia
  • Science & Technology
  • TISSUE
  • VALIDATION
  • VARIABLE SELECTION METHODS

Digital Object Identifier (DOI)

publisher

  • ELSEVIER IRELAND LTD

start page

  • 18

end page

  • 29

volume

  • 272